Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation. [electronic resource]
Producer: 20201210Description: 91-93 p. digitalISSN:- 1499-3872
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain Neoplasms -- secondary
- Carcinoma, Hepatocellular -- drug therapy
- Chemoembolization, Therapeutic
- Fatal Outcome
- Hepatectomy
- Humans
- Immune Checkpoint Inhibitors -- therapeutic use
- Liver Neoplasms -- drug therapy
- Liver Transplantation -- adverse effects
- Lung Neoplasms -- secondary
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.